Actively Recruiting
Study on the Value of Musculoskeletal Cross-modal Imaging Assessment System in the Diagnosis and Prognosis of Sarcopenia in Lung Cancer Patients
Led by West China Hospital · Updated on 2024-03-25
1500
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a musculoskeletal cross-modal imaging system combining ultrasound with abdominal CT/MRI to diagnose sarcopenia in patients with lung cancer. The study aims to assess how this system can predict prognosis and the effects of nutritional support during the perioperative period, as well as the long-term outcomes for these patients. Sarcopenia involves loss of muscle mass and function and is common in lung cancer, affecting recovery and survival. Participants scheduled for radical lung cancer surgery will undergo whole-body ultrasound scans focusing on muscle and fat, along with abdominal CT/MRI scans. These imaging tests are used together to provide a more comprehensive and stable diagnosis of sarcopenia. The study compares lung cancer patients with and without sarcopenia to evaluate the imaging system's diagnostic and prognostic value. During the study, participants will be monitored for perioperative complications within 7 days after surgery and for survival over 2 years from the initial ultrasound exam. Researchers will collect imaging data and track outcomes related to nutritional support and long-term prognosis. The study involves hospitalized adults aged 40 to 100 years who have had a recent CT/MRI and are compliant with examinations. The total participation timeline extends up to 2 years for outcome assessments.
CONDITIONS
Brief Title
Assessment System of Sarcopenia in Lung Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospitalized patients scheduled for radical resection of lung cancer
- Had a CT or MRI examination within 1 week before enrollment
- Able to comply with study examinations and procedures
You will not qualify if you...
- Amputated arm or leg
- Severe swelling in legs above knee level
- Having an implantable pacemaker
- Impaired consciousness or poor general health preventing study completion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Within 1 week before surgery
Participants undergo ultrasound and abdominal CT/MRI scans to assess muscle thickness and cross-sectional area for sarcopenia diagnosis.
1 to 2 visits depending on imaging schedules
Duration - Up to 2 years after initial ultrasound examination
Participants are observed for perioperative complications and survival outcomes following lung cancer surgery.
Follow-up visits within 7 days after surgery and periodic monitoring up to 2 years
Trial Site Locations
Total: 1 location
1
Xinyi Tang
Chengdu, Sichuan, China
Actively Recruiting
Research Team
X
Xinyi Tang, Dr.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here